retatrutide study results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Lilly orforglipron oral GLP-1 phase
Description
While neither drug is officially approved by the FDA for weight loss, they are frequently used off-label for this purpose
T.YinW.GarousiJ.GrslundT.et al (2024)
These serious side effects are rare but require immediate medical attention regardless of whether you are using drops or injections
Those working with tirzepatide reconstitution should follow established protocols to ensure consistent potency and predictable effects
Still, GLP-3 does not describe a correct drug class
Starting Dose for Retatrutide The recommended retatrutide starting dose is 2mg once weekly
